The 20 Best Nearsightedness Doctors Near Me in Baltimore, MD

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy. Dr. Repka is board certified in American Board Of Ophthalmology.

Dr. Kraig Scot Bower is an associate professor of ophthalmology and the director of refractive surgery at the Wilmer Eye Institute. He specializes in refractive surgery (LASIK), cornea and external diseases of the eye and anterior segment surgery. Dr. Bower is a retired Army colonel, Medical Corps. From 2001 to 2010, he was the director of refractive surgery at Walter Reed Army Medical Center and served as the Army's refractive surgery subject matter expert, advising the Army Surgeon General on laser refractive surgery and managing the Army's Warfighter Refractive Eye Surgery Program. Dr. Bower is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Keratoconus, Astigmatism, Cataract, and Nearsightedness. Dr. Bower is board certified in American Board Of Ophthalmology.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology.

Wendy Bohner is an Ophthalmologist practicing medicine in Cockeysville, Maryland. Dr. Bohner is rated as a Distinguished provider by MediFind in the treatment of Nearsightedness. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Nearsightedness, Cataract, Dry Eye Syndrome, and Glaucoma.

Frederick Sauerburger is an Ophthalmologist practicing medicine in Waldorf, Maryland. Dr. Sauerburger is rated as a Distinguished provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Nearsightedness, Astigmatism, Cataract, and Eyelid Bump.

Michael Grodin is an Ophthalmologist practicing medicine in Lutherville Timonium, Maryland. Dr. Grodin is rated as a Distinguished provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion.

Dr. Brooks G. Brown III is an ophthalmologist affiliated with Sibley Memorial Hospital. He practices out of Chevy Chase, Maryland. Dr. Brown earned his medical degree from George Washington University School of Medicine. He completed a residency in ophthalmology at MedStar Washington Hospital Center. Dr. Brown is a fellow of the American Academy of Ophthalmology. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Blepharitis, Chalazion, Cataract, and Eyelid Bump. Dr. Brown is board certified in American Board Of Ophthalmology.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology.

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy. Dr. Gehlbach is board certified in American Board Of Ophthalmology.

Courtney L. Kraus, M.D., is Knights Templar Eye Foundation Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Kraus specializes in pediatric ophthalmology and adult strabismus, including amblyopia (lazy eye), with a particular interest in pediatric cataract and corneal diseases. She has enjoyed participating in surgical mission trips to underserved areas in the developing world. Dr. Kraus received her medical degree from Washington University in St. Louis, Missouri, where she also completed her residency in ophthalmology after an internship in internal medicine at St. John’s Mercy Medical Center in Creve Coeur, Missouri. She then completed a fellowship in pediatric ophthalmology and adult strabismus at the Storm Eye Institute at The Medical University of South Carolina. Dr. Kraus is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Strabismus, Idiopathic Short Stature (ISS), Brown Syndrome, Vitrectomy, and Cataract Removal. Dr. Kraus is board certified in American Board Of Ophthalmology.

Mandeep S. Singh, M.D., Ph.D., is associate professor of ophthalmology and genetic medicine in the Retina Division of the Wilmer Eye Institute and the recipient of the 2023 Andreas C. Dracopoulos Professorship in Ophthalmology. Dr. Singh is a retinal specialist. He is Co-Director of the Genetic Eye Disease (GEDi) Center, and is a principal investigator at the Center for Stem Cells and Ocular Regenerative Medicine (STORM). Dr. Singh completed his medical degree at the National University of Singapore. In 2009, he was elected to the Fellow of the Royal College of Surgeons of Edinburgh. He earned a PhD in ophthalmology from the University of Oxford, United Kingdom, in 2014. He completed fellowships in vitreoretinal diseases and surgery at the Oxford Eye Hospital and Moorfields Eye Hospital, both in the United Kingdom. His clinical expertise includes surgical, medical and genetic conditions of the retina and macula. Dr. Singh is specialty-trained in vitrectomy surgery for retinal detachment, macular holes, macular pucker, epiretinal membrane, proliferative vitreoretinopathy, complex retinal detachments including reoperations, vitreous hemorrhage removal, and other retinal surgeries. He also specializes in age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion, and choroidal neovascularization. Dr. Singh sees patients and families with genetic retinal diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and macular dystrophies. His research focus is retinal stem cell transplantation. Dr. Singh’s work has been recognized through the Eye Institute–Allergan Research Prize, the Merton College University of Oxford Graduate Prize Scholarship, the Oxford Ophthalmological Congress Founder’s Cup and Medal, the Ruskell Medal, the Johns Hopkins Clinician Scientist Award, and the Bert M. Glaser, MD Award for Innovative Research in Retina. He is a member of the American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology. He is also a member of the Club Jules Gonin and the Macula Society. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Singh_CV.pdf. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Retinitis Pigmentosa, Stargardt Macular Degeneration, Late-Onset Retinal Degeneration, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy. Dr. Handa is board certified in American Board Of Ophthalmology.

Bryce Chiang, M.D., Ph.D., is an assistant professor of ophthalmology and a glaucoma specialist at the Wilmer Eye Institute, Johns Hopkins Medicine East Baltimore location. His clinical interests include the medical and surgical management of glaucoma and cataract. After receiving his combined bachelor’s/master’s degrees in biomedical engineering from The Johns Hopkins University, Dr. Chiang completed joint M.D./Ph.D. degrees at the Emory University School of Medicine. During his doctorate in biomedical engineering at the Georgia Institute of Technology, Dr. Chiang became interested in ophthalmology through his research in ocular drug delivery. He served as a medicine intern at Highland Hospital in Oakland, California, and completed his ophthalmology residency, glaucoma fellowship and innovation fellowship at the Byers Eye Institute at Stanford University. Dr. Chiang’s research interests include targeted ocular drug delivery, specifically within the suprachoroidal space and to the optic nerve head. He studied the pharmacokinetics of microneedle injections into the suprachoroidal space while pursuing his doctorate at Georgia Tech, and maintains an interest in the suprachoroidal space as a means of altering disease trajectory. Furthermore, despite the optic nerve head being the site of disease in optic neuropathies, no therapies exist that treat the optic nerve head. By directly treating the diseased tissue, targeting therapeutics to the optic nerve head may enable paradigm shifting therapies for optic neuropathies. Targeted delivery to the optic nerve head may also serve as a research tool to query the pathogenesis of glaucoma. Dr. Chiang is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Uveitis, and Nearsightedness.

Dr. Harry A. Quigley is the A. Edward Maumenee Professor of Ophthalmology and developed the Glaucoma Division at the Johns Hopkins Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for 8 years as its Secretary and was elected to 5 year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and editor-in-chief of Investigative Ophthalmology and Visual Science. He has published over 350 peer-reviewed articles, and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity and progression rate of glaucoma and other eye disease in American, African, Asian and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats and mice. Dr. Quigley is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy. Dr. Quigley is board certified in American Board Of Ophthalmology.

Jefferson Doyle, M.D., Ph.D., M.H.S. specializes in pediatric ophthalmology and genetic eye diseases and is the recipient of the 2023 Andreas C. Dracopoulos & Daniel Finkelstein, M.D. Rising Professorship in Ophthalmology. His main focus is pediatric and juvenile forms of cataracts, glaucoma, anterior segment dysgenesis, and ectopia lentis. His genetics interests include Marfan syndrome and related connective tissue disorders, complex inherited forms of strabismus in both children and adults (e.g. CFEOM, Duane syndrome), and pediatric retinal dystrophies. Dr. Doyle has published extensively on a number of genetic disorders over the past decade, holds several patents for novel therapeutic approaches to treat them, and has given many national and international talks about them. Dr. Doyle's main research focus is understanding the genetic causes and molecular mechanisms driving genetic diseases, and utilizing that knowledge to develop new therapeutic strategies for them. Over the past decade, he has played a significant role in advancing our understanding of Marfan syndrome and related connective tissue disorders. His work and that of collaborators has led to the discovery of the genetic causes of Shprintzen-Goldberg syndrome and Loeys-Dietz like syndrome. His work has also led to a much better understanding of the molecular mechanisms driving Marfan syndrome, and he holds two patents for novel therapeutic strategies to treat it. Part of his current work focuses on the identification of genes that protect people from developing a number of genetic disorders, and leveraging that knowledge to develop new therapies for those diseases. He also has an interest in pediatric myopia, and has ongoing pre-clinical studies seeking to understand the mechanisms that may drive it and the development of novel therapeutic strategies to treat it. Recent News Articles and Media Coverage A Center for Genetic Eye Disease, Wilmer Insider (Oct. 2021). Dr. Doyle is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Duane-Radial Ray Syndrome, Ehlers-Danlos Syndrome (EDS), Strabismus, and Hereditary Keratitis. Dr. Doyle is board certified in American Board Of Ophthalmology.

"Dr. Shah is an AUPO-fellowship trained ophthalmologist specializing in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona. Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital's highest award for training physicians – ""Excellence in Clinical Practice for a Fellow, Resident, or Intern."" Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.". Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Orbital Cellulitis, Hyphema, Kallikrein Hypertension, and Optic Nerve Atrophy. Dr. Shah is board certified in American Board Of Ophthalmology.

Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration. Dr. Sodhi is board certified in American Board Of Ophthalmology.

Shameema Sikder, M.D. is an ophthalmologist who specializes in corneal disorders, such as Fuchs' dystrophy and keratoconus, as well as complex cataracts. Dr. Sikder's clinical interests include surgical treatments for corneal diseases, such as endothelial keratoplasty (DMEK, DSAEK), complex cataracts, and treatments for keratoconus. Dr. Sikder is the director of the Center of Excellence for Ophthalmic Surgical Education and Training (OphSET) at the Johns Hopkins Hospital. Dr. Sikder also has a faculty appointment at the Malone Center for Engineering in Healthcare at Johns Hopkins University. She has a particular interest in surgical education and through NIH support, is working on technologies that could be implemented at the international level to improve the level of ophthalmic surgical care. Dr. Sikder received her M.D. degree from the University of Arizona after obtaining Bachelor's degrees in Chemical Engineering and Biochemistry. She completed her ophthalmology residency at the Wilmer Eye Institute and fellowship in cornea and refractive disease at the Moran Eye Institute in Salt Lake City, Utah, where she received the Claes Dohlman Fellow of the Year Award, recognizing the most distinguished cornea fellow in the nation. Dr. Sikder returned to Wilmer in 2011 and served as assistant chief of service (chief resident) and associate director of ocular trauma. She was the inaugural medical director of the Wilmer Eye Institute in Bethesda in 2014, where she continues to care for patients. Dr. Sikder is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cataract, Pterygium, Fuchs Dystrophy, Cataract Removal, and Corneal Transplant. Dr. Sikder is board certified in American Board Of Ophthalmology.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Cataract, Optic Atrophy Type 1, Vitrectomy, and Cataract Removal.

Dr. Couser obtained his bachelor’s degree from the University of Virginia and his Medical Doctorate from the Virginia Commonwealth University School of Medicine (VCU SOM). Dr. Couser’s ophthalmology residency was completed at Howard University where he served as co-chief resident in the last year of his residency. He received fellowship training in pediatric ophthalmology and adult strabismus at Emory University. Dr. Couser received a master’s degree in biotechnology from the Johns Hopkins University and completed a residency in clinical genetics at the University of North Carolina at Chapel Hill. He is one of only a few individuals currently board-certified by both the American Board of Ophthalmology and the American Board of Medical Genetics and Genomics. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/couser-cv Research Summary My primary research focus involves the identification and management of genetic eye diseases including rare inherited disorders affecting the eyes. Research and scholarly activities have been an integral component of my career path. I have been the principal investigator on 10 clinical trial/IRB studies and a co-investigator on others, participated with several committees or advisory panels related to research activities. I have been credited with over 120 book chapter, journal article and abstract publications. In addition, I served as the primary author/sole editor for a textbook titled Ophthalmic Genetic Diseases: A Quick Reference Guide to the Eye and External Ocular Adnexa Abnormalities, 1st Edition, published by Elsevier in 2018, which is one of only a few textbooks published in this subject area. I also served as a grant review panelist for the National Eye Institute Career Development Awards. Selected Publications *Couser NL, Masood MM, Strande NT, Foreman AKM, Crooks K, Weck KE, Lu M, Wilhelmsen KC, Roche M, Evans JP, Berg JS, Powell CM. 2015. The phenotype of multiple congenital anomalies- hypotonia-seizures syndrome 1: Report and review. Am J Med Genet Part A 9999A:1–6 *Couser NL, Lambert SR. Botulinum toxin: A treatment of consecutive esotropia in children. Strabismus 2012; 20(4):158-161 Couser NL, Lenhart PD, Hutchinson AK. Augmented Hummelsheim procedure to treat complete abducens nerve palsy. J AAPOS 2012;16(4):331-5 *Natario L. Couser, Maheer M. Masood, Arthur S. Aylsworth, and Roger E. Stevenson. Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genet. 2017, Jan 23:1-12 *Couser NL, Brooks BP, Drack AV, Shankar SP. The evolving role of genetics in ophthalmology. Ophthalmic Genet. 2021 Jan 12:1-4. doi: 10.1080/13816810.2020.1868011. Dr. Couser is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Epicanthal Folds, Strabismus, Hypotonia, and Brown Syndrome. Dr. Couser is board certified in American Board Of Medical Genetics And Genomics and American Board Of Ophthalmology.